Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3476 | 1975 | 29.8 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
567 | 2 | MALT LYMPHOMA//LYMPHOMA//PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | 14422 |
3476 | 1 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA//PRIMARY CNS LYMPHOMA//PCNSL | 1975 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | authKW | 2682163 | 12% | 74% | 236 |
2 | PRIMARY CNS LYMPHOMA | authKW | 1748924 | 7% | 77% | 147 |
3 | PCNSL | authKW | 865870 | 3% | 81% | 69 |
4 | CNS LYMPHOMA | authKW | 479950 | 3% | 55% | 56 |
5 | CENTRAL NERVOUS SYSTEM LYMPHOMA | authKW | 400997 | 2% | 62% | 42 |
6 | BRAIN LYMPHOMA | authKW | 213032 | 1% | 66% | 21 |
7 | LYMPHOMATOSIS CEREBRI | authKW | 204603 | 1% | 88% | 15 |
8 | PRIMARY CEREBRAL LYMPHOMA | authKW | 139121 | 1% | 60% | 15 |
9 | HIGH DOSE METHOTREXATE | authKW | 130455 | 2% | 26% | 33 |
10 | PRIMARY DURAL LYMPHOMA | authKW | 123673 | 0% | 100% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 14893 | 38% | 0% | 752 |
2 | Oncology | 9328 | 36% | 0% | 715 |
3 | Hematology | 2820 | 12% | 0% | 240 |
4 | Pathology | 2343 | 10% | 0% | 203 |
5 | Radiology, Nuclear Medicine & Medical Imaging | 1348 | 11% | 0% | 221 |
6 | Neuroimaging | 1321 | 3% | 0% | 66 |
7 | Surgery | 630 | 12% | 0% | 229 |
8 | Neurosciences | 441 | 11% | 0% | 220 |
9 | Medicine, General & Internal | 282 | 7% | 0% | 142 |
10 | Pediatrics | 38 | 3% | 0% | 51 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT LYMPHOID MALIGNANCIES | 55962 | 1% | 15% | 24 |
2 | UNITE CYTOKINES CANC | 38643 | 0% | 50% | 5 |
3 | HEMATOL ONCOL TRANSFUS MED | 35242 | 1% | 13% | 18 |
4 | LOC EXPERT | 30918 | 0% | 100% | 2 |
5 | NORWEGIAN ONCOL | 30918 | 0% | 100% | 2 |
6 | RADIOCHEMOTHER Y | 27771 | 1% | 14% | 13 |
7 | RADIOTHER Y MED ONCOL | 24148 | 0% | 31% | 5 |
8 | NEUROONCOLSEATTLE CANC CARE ALLIANCE | 20611 | 0% | 67% | 2 |
9 | PARTNERS NEUROL IDENCY PROGRAM | 20611 | 0% | 67% | 2 |
10 | CLIN EPIDEMIOL PL BIOSTAT | 19867 | 0% | 21% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURO-ONCOLOGY | 47628 | 7% | 2% | 129 |
2 | LEUKEMIA & LYMPHOMA | 5222 | 3% | 1% | 51 |
3 | DEVELOPMENTS IN ONCOLOGY | 4904 | 1% | 2% | 20 |
4 | CLINICAL NEUROPATHOLOGY | 4276 | 1% | 1% | 20 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 2910 | 3% | 0% | 56 |
6 | NEUROPATHOLOGY | 2738 | 1% | 1% | 16 |
7 | SURGICAL NEUROLOGY | 2437 | 1% | 1% | 29 |
8 | NEURO-ONCOLOGY | 2408 | 0% | 3% | 6 |
9 | ANNALS OF ONCOLOGY | 2379 | 2% | 0% | 36 |
10 | BRAIN TUMOR PATHOLOGY | 2303 | 0% | 2% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | 2682163 | 12% | 74% | 236 | Search PRIMARY+CENTRAL+NERVOUS+SYSTEM+LYMPHOMA | Search PRIMARY+CENTRAL+NERVOUS+SYSTEM+LYMPHOMA |
2 | PRIMARY CNS LYMPHOMA | 1748924 | 7% | 77% | 147 | Search PRIMARY+CNS+LYMPHOMA | Search PRIMARY+CNS+LYMPHOMA |
3 | PCNSL | 865870 | 3% | 81% | 69 | Search PCNSL | Search PCNSL |
4 | CNS LYMPHOMA | 479950 | 3% | 55% | 56 | Search CNS+LYMPHOMA | Search CNS+LYMPHOMA |
5 | CENTRAL NERVOUS SYSTEM LYMPHOMA | 400997 | 2% | 62% | 42 | Search CENTRAL+NERVOUS+SYSTEM+LYMPHOMA | Search CENTRAL+NERVOUS+SYSTEM+LYMPHOMA |
6 | BRAIN LYMPHOMA | 213032 | 1% | 66% | 21 | Search BRAIN+LYMPHOMA | Search BRAIN+LYMPHOMA |
7 | LYMPHOMATOSIS CEREBRI | 204603 | 1% | 88% | 15 | Search LYMPHOMATOSIS+CEREBRI | Search LYMPHOMATOSIS+CEREBRI |
8 | PRIMARY CEREBRAL LYMPHOMA | 139121 | 1% | 60% | 15 | Search PRIMARY+CEREBRAL+LYMPHOMA | Search PRIMARY+CEREBRAL+LYMPHOMA |
9 | HIGH DOSE METHOTREXATE | 130455 | 2% | 26% | 33 | Search HIGH+DOSE+METHOTREXATE | Search HIGH+DOSE+METHOTREXATE |
10 | PRIMARY DURAL LYMPHOMA | 123673 | 0% | 100% | 8 | Search PRIMARY+DURAL+LYMPHOMA | Search PRIMARY+DURAL+LYMPHOMA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOTTINGER, AF , PREUSSER, M , RUDA, R , SCHLEGEL, T , SOUSSAIN, C , ABACIOGLU, U , CASSOUX, N , DECKERT, M , DIRVEN, SMF , FERRERI, AJM , ET AL (2015) DIAGNOSIS AND TREATMENT OF PRIMARY CNS LYMPHOMA IN IMMUNOCOMPETENT PATIENTS: GUIDELINES FROM THE EUROPEAN ASSOCIATION FOR NEURO-ONCOLOGY.LANCET ONCOLOGY. VOL. 16. ISSUE 7. P. E322 -E332 | 85 | 97% | 14 |
2 | DEL RIO, MS , ROUSSEAU, A , SOUSSAIN, C , RICARD, D , HOANG-XUAN, K , (2009) PRIMARY CNS LYMPHOMA IN IMMUNOCOMPETENT PATIENTS.ONCOLOGIST. VOL. 14. ISSUE 5. P. 526-539 | 104 | 91% | 42 |
3 | PHILLIPS, EH , FOX, CP , CWYNARSKI, K , (2014) PRIMARY CNS LYMPHOMA.CURRENT HEMATOLOGIC MALIGNANCY REPORTS. VOL. 9. ISSUE 3. P. 243 -253 | 85 | 90% | 8 |
4 | ROTH, P , KORFEL, A , MARTUS, P , WELLER, M , (2012) PATHOGENESIS AND MANAGEMENT OF PRIMARY CNS LYMPHOMA.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 12. ISSUE 5. P. 623-633 | 94 | 87% | 9 |
5 | FERRERI, AJM , (2011) HOW I TREAT PRIMARY CNS LYMPHOMA.BLOOD. VOL. 118. ISSUE 3. P. 510 -522 | 80 | 89% | 61 |
6 | KORFEL, A , SCHLEGEL, U , (2013) DIAGNOSIS AND TREATMENT OF PRIMARY CNS LYMPHOMA.NATURE REVIEWS NEUROLOGY. VOL. 9. ISSUE 6. P. 317-327 | 79 | 86% | 26 |
7 | CARNEVALE, J , RUBENSTEIN, JL , (2016) THE CHALLENGE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 30. ISSUE 6. P. 1293 -+ | 94 | 76% | 0 |
8 | BRASTIANOS, PK , BATCHELOR, TT , (2012) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA OVERVIEW OF CURRENT TREATMENT STRATEGIES.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 26. ISSUE 4. P. 897-+ | 78 | 95% | 8 |
9 | RUBENSTEIN, JL , GUPTA, NK , MANNIS, GN , LAMARRE, AK , TRESELER, P , (2013) HOW I TREAT CNS LYMPHOMAS.BLOOD. VOL. 122. ISSUE 14. P. 2318-2330 | 83 | 75% | 21 |
10 | GONZALEZ-AGUILAR, A , HOUILLIER, C , SOUSSAIN, C , HOANG-XUAN, K , (2011) MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA.REVUE NEUROLOGIQUE. VOL. 167. ISSUE 10. P. 721-728 | 78 | 92% | 1 |
Classes with closest relation at Level 1 |